Dominari Holdings

Dominari Holdings

Dominari Holdings dates to 1967 but found its current identity under CEO Kyle Wool, who joined as the pandemic-era biotech bubble deflated. Previously known as AIkido Pharma, the company once incubated drug-discovery assets tied to universities including the University of Texas and Wake Forest. Those early-stage bets largely ran their course, and Wool executed a hard reset: the firm sold legacy biotech positions, rebranded, and layered on a financial-services strategy through a controlling stake in Dominari Securities, a registered broker-dealer. The firm now operates on two parallel tracks. On the financial-services side, Dominari Securities provides investment banking and advisory services to small- and mid-cap companies, while Dominari's SPAC, Dominari Acquisition Corp., actively seeks a target in biotechnology or related sectors — making the firm both a potential issuer and an underwriter. On the biotech side, the company retains select research-stage assets, though specific portfolio names have not been disclosed in recent public filings. Its geographic footprint is concentrated in the United States, with all regulatory registrations pointing to a New York base. Team size and total deployment are not publicly disclosed. In August 2024, Dominari Acquisition Corp. filed with the SEC to extend its deadline for completing a business combination, signaling an active but cautious SPAC search in a market that has soured on blank-check companies. The parent company also holds a stake in an entity called DatChat, a messaging-app developer, which sits outside its core biotech and financial-services mandate. Structurally, Dominari is a micro-cap holding company with a fully internal capital-markets arm — the broker-dealer can underwrite equity offerings for the parent's portfolio companies, creating a loop that larger firms typically segregate. This architecture allows Dominari to retain economics at multiple layers of a deal but also concentrates operational and compliance risk inside a single public entity with a market capitalization that fluctuates in the low tens of millions.